Pyxis Oncology CEO Exercises Zero‑Cost Stock Options, Signaling New Strategic Drive and Long‑Term Confidence in Growth
Pyxis Oncology’s CEO exercises zero‑price options, signaling confidence and long‑term commitment to new therapies and potential upside for investors.
2 minutes to read